{"id":"https://openalex.org/W2599428142","doi":"https://doi.org/10.1007/s40262-017-0528-2","title":"Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment","display_name":"Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment","alternate_titles":[],"publication_year":2017,"publication_date":"2017-03-27","ids":{"openalex":"https://openalex.org/W2599428142","doi":"https://doi.org/10.1007/s40262-017-0528-2","mag":"2599428142","pmid":"https://pubmed.ncbi.nlm.nih.gov/28349386","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5648736"},"language":"en","primary_location":{"id":"doi:10.1007/s40262-017-0528-2","doi":"https://doi.org/10.1007/s40262-017-0528-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-017-0528-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-017-0528-2.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2599428142"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40262-017-0528-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028366409","display_name":"Thomas C Marbury","orcid":"https://orcid.org/0000-0002-6416-3314","observed_orcids":["https://orcid.org/0000-0002-6416-3314"]},"institutions":[{"id":"https://openalex.org/I4210087159","display_name":"Orlando Clinical Research Center","ror":"https://ror.org/000x1tr98","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210087159"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas C. Marbury","raw_affiliation_strings":["Orlando Clinical Research Center, 5055 South Orange Avenue, Orlando, FL, 32809, USA. tmarbury@ocrc.net","Orlando Clinical Research Center, 5055 South Orange Avenue, Orlando, FL, 32809, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando Clinical Research Center, 5055 South Orange Avenue, Orlando, FL, 32809, USA. tmarbury@ocrc.net","institution_ids":["https://openalex.org/I4210087159"]},{"raw_affiliation_string":"Orlando Clinical Research Center, 5055 South Orange Avenue, Orlando, FL, 32809, USA","institution_ids":["https://openalex.org/I4210087159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019076349","display_name":"Anne Flint","orcid":"https://orcid.org/0000-0003-1604-8714","observed_orcids":["https://orcid.org/0000-0003-1604-8714"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Anne Flint","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110457964","display_name":"Jacob Bonde Jacobsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jacob B. Jacobsen","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008923622","display_name":"Julie Derving Karsb\u00f8l","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Julie Derving Karsb\u00f8l","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061427649","display_name":"Kenneth C. Lasseter","orcid":"https://orcid.org/0000-0001-8175-2199","observed_orcids":["https://orcid.org/0000-0001-8175-2199"]},"institutions":[{"id":"https://openalex.org/I4210123890","display_name":"Clinical Pharmacology of Miami","ror":"https://ror.org/02wvtac27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210123890"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Lasseter","raw_affiliation_strings":["Clinical Pharmacology of Miami, Inc., Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology of Miami, Inc., Miami, FL, USA","institution_ids":["https://openalex.org/I4210123890"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028366409"],"corresponding_institution_ids":["https://openalex.org/I4210087159"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":9.7152,"has_fulltext":true,"cited_by_count":143,"citation_normalized_percentile":{"value":0.988342,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"56","issue":"11","first_page":"1381","last_page":"1390"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1-analog","display_name":"glucagon-like peptide-1 analogues","score":0.9549999833106995},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.871999979019165},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9359999895095825},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.9010000228881836},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.7509999871253967},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.859000027179718},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7620000243186951},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7590000033378601},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8190000057220459},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.9330000281333923}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9871155619621277},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7972846031188965},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7538280487060547},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5959640741348267},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5310312509536743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5039083361625671},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4724997282028198},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4324760138988495},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4204457402229309},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.38667547702789307},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.376731276512146},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.37164226174354553},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3256503939628601},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.23232188820838928},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.07095655798912048}],"mesh":[{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s40262-017-0528-2","doi":"https://doi.org/10.1007/s40262-017-0528-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-017-0528-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-017-0528-2.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:28349386","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28349386","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Controlled Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:5648736","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5648736/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacokinet","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s40262-017-0528-2","doi":"https://doi.org/10.1007/s40262-017-0528-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-017-0528-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-017-0528-2.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2599428142.pdf","grobid_xml":"https://content.openalex.org/works/W2599428142.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W1969235489","https://openalex.org/W1971244959","https://openalex.org/W1971506354","https://openalex.org/W1974411409","https://openalex.org/W1978864090","https://openalex.org/W1985650809","https://openalex.org/W1997042641","https://openalex.org/W2001097346","https://openalex.org/W2011053378","https://openalex.org/W2021055445","https://openalex.org/W2047286813","https://openalex.org/W2050304493","https://openalex.org/W2054088567","https://openalex.org/W2055073896","https://openalex.org/W2084948079","https://openalex.org/W2089652721","https://openalex.org/W2096971003","https://openalex.org/W2113389249","https://openalex.org/W2117764934","https://openalex.org/W2120449552","https://openalex.org/W2122808146","https://openalex.org/W2140536043","https://openalex.org/W2146702281","https://openalex.org/W2155891679","https://openalex.org/W2156364071","https://openalex.org/W2160850704","https://openalex.org/W2236659707","https://openalex.org/W2464122426","https://openalex.org/W2519510391","https://openalex.org/W2595209157"],"related_works":["https://openalex.org/W2795981708","https://openalex.org/W4321437501","https://openalex.org/W2773698516","https://openalex.org/W2800291410","https://openalex.org/W2140536043","https://openalex.org/W4392654922","https://openalex.org/W2565696656","https://openalex.org/W4400011861","https://openalex.org/W4322496062","https://openalex.org/W2807957707"],"abstract_inverted_index":{"The":[0],"pharmacokinetics":[1,186],"and":[2,41,86,118,139,165,171,198,222,233],"tolerability":[3],"of":[4,17,51,106,187],"semaglutide,":[5],"a":[6,47],"once-weekly":[7],"human":[8],"glucagon-like":[9],"peptide-1":[10],"analog":[11],"in":[12,24,81,92,112,136,192,219],"development":[13],"for":[14,124,134,217,250],"the":[15,63,67,70,103,119,125,128,143,149,185],"treatment":[16],"type":[18],"2":[19],"diabetes":[20],"mellitus,":[21],"were":[22,58,147,203],"investigated":[23],"subjects":[25,82,93,99,113,230,234,251],"with/without":[26],"renal":[27,34,43,96,116,237],"impairment":[28],"(RI).":[29],"Fifty-six":[30],"subjects,":[31],"categorized":[32],"into":[33],"function":[35],"groups":[36,156],"[normal,":[37],"mild,":[38],"moderate,":[39],"severe,":[40],"end-stage":[42],"disease":[44],"(ESRD)],":[45],"received":[46],"single":[48],"subcutaneous":[49],"dose":[50],"semaglutide":[52,107,166,172,225],"0.5":[53],"mg.":[54],"Semaglutide":[55,79,239],"plasma":[56,71,174],"concentrations":[57],"assessed":[59],"\u2264480":[60],"h":[61],"post-dose;":[62],"primary":[64],"endpoint":[65],"was":[66,88,108,158,227,242],"area":[68],"under":[69],"concentration\u2013time":[72],"curve":[73],"from":[74],"time":[75],"zero":[76],"to":[77,90,183],"infinity.":[78],"exposure":[80,105,226],"with":[83,94,100,114,207,231,235,252],"mild/moderate":[84],"RI":[85,155,209,232],"ESRD":[87],"similar":[89,228],"that":[91],"normal":[95,115,236],"function.":[97,238],"In":[98],"severe":[101,208],"RI,":[102],"mean":[104],"22%":[109],"higher":[110],"than":[111],"function,":[117],"95%":[120],"confidence":[121],"interval":[122],"(1.02\u20131.47)":[123],"ratio":[126],"exceeded":[127],"pre-specified":[129,150],"limits":[130],"(0.70\u20131.43).":[131],"When":[132,215],"adjusted":[133,216],"differences":[135,218],"sex,":[137,220],"age,":[138,221],"body":[140,223],"weight":[141],"between":[142,161,169,229],"groups,":[144],"all":[145],"comparisons":[146],"within":[148],"clinically":[151],"relevant":[152],"limits.":[153],"Across":[154],"there":[157],"no":[159,199],"relationship":[160],"creatinine":[162],"clearance":[163],"(CLCR)":[164],"exposure,":[167],"or":[168,195],"CLCR":[170],"maximum":[173],"drug":[175],"concentration":[176],"(C":[177],"max).":[178],"Hemodialysis":[179],"did":[180],"not":[181,247],"appear":[182],"affect":[184],"semaglutide.":[188],"No":[189],"appreciable":[190],"changes":[191],"safety":[193],"parameters":[194],"vital":[196],"signs":[197],"serious":[200],"adverse":[201],"events":[202],"noted.":[204],"One":[205],"subject":[206],"reported":[210],"two":[211],"major":[212],"hypoglycemic":[213],"events.":[214],"weight,":[224],"(0.5":[240],"mg)":[241],"well-tolerated.":[243],"Dose":[244],"adjustment":[245],"may":[246],"be":[248],"warranted":[249],"RI.":[253],"NCT00833716.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2599428142","counts_by_year":[{"year":2026,"cited_by_count":21},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":23},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":19},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2017-04-07T00:00:00"}
